Contineum Therapeutics CTNM
NASDAQ CTNM
$16.70 -0.87 (-4.95%)
As of: Sep 4, 2026 · 3:59 PM EDT

Contineum Therapeutics (CTNM) Property, Plant & Equipment (Net) (2023 - 2026)

Analysis

Contineum Therapeutics (CTNM) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Contineum Therapeutics 628.71 Mn 628.71 Mn - 929,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 929,000.00
Mar 31, 2026 1.06 Mn
Dec 31, 2025 830,000.00
Sep 30, 2025 880,000.00
Jun 30, 2025 856,000.00
Mar 31, 2025 891,000.00
Dec 31, 2024 989,000.00
Sep 30, 2024 888,000.00
Jun 30, 2024 801,000.00
Mar 31, 2024 756,000.00
Dec 31, 2023 678,000.00